Overweight with disciplined tiered architecture; start at ~1% at $337, add confirmation-gated on pullbacks to $325-329 and $319, max 2.5-3% exposure, hard stop at $305.
JPM is a great franchise (17.79% ROE, record revenue, defensive balance sheet, $756B liquidity, 1.6x tangible book, $50B annual capital return) but suboptimal trade given 6/7 bearish technical factors, MACD histogram at -2.03 and expanding, lower Bollinger Band test in progress, and $1.5T+ AFS portfolio carrying mark-to-market drag in a 30Y at 2004-highs regime. Overweight conviction is warranted based on fundamental quality and prior decision history lessons (flat-weight Holds underperformed, Underweights missed franchise floor support), but position must be disciplined and confirmation-gated rather than aggressive. Price target $370.
| Position | Action |
|---|---|
| Initial position | ~1% portfolio weight at Tier 1 entry price $337 |
| On confirmation: close above lower Bollinger + MACD histogram contracting | Add to Tier 2 at $325-329 |
| On high-volume reversal bar | Add to Tier 3 at $319/200 SMA |
| Maximum exposure cap | 2.5-3% total single-name concentration |
JPM is a high-quality compounder on sale—technical weakness (RSI 35, MACD -3.29, price touching lower Bollinger Band at $338.73) creates a contrarian entry point into a franchise printing record earnings (47% YoY EPS growth), generating $50B annual capital returns, and benefiting from a structurally NIM-positive higher-for-longer macro backdrop.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 346.01 | bearish |
| 50 SMA | 353.35 | bearish |
| 200 SMA | 319.38 | bullish |
| RSI(14) | 35.05 | bearish |
| MACD Line | -3.29 | bearish |
| MACD Signal Line | -1.26 | bearish |
| MACD Histogram | -2.03 | bearish |
| Bollinger Upper Band | 364.91 | neutral |
| Bollinger Middle Band (20 SMA) | 351.82 | neutral |
| Bollinger Lower Band | 338.73 | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close above lower Bollinger Band + MACD histogram contracting
Then: Add at $325-329
RSI 35 is a contrarian buy signal in a high-quality compounder, not a continuation trigger
↩ rebuts: “Bear's 'RSI 35, no bullish divergence yet' argument”
· concedes: The short-term momentum is indeed weak (RSI 35, MACD -3.29, bearish stack on 6 of 7 factors); The Polymarket recession probability has risen 1pp to 10%, representing some deterioration in macro backdrop; Special charges of $4.39B in Q2 are material; The $6-7 downside risk to $325-329 exists if the 200 SMA is broken; Distribution on volume is occurring, though likely from weak hands being absorbed by buybacks
JPM is a cyclical bank at a cyclical top in rates, priced for a continuation of a regime that is showing clear signs of exhausting itself. Quality is not a sufficient defense against a macro regime shift.
· concedes: JPM is the highest-quality franchise in U.S. banking; JPM is not a bad business — the bear case is about repricing, not permanent impairment; The bear case doesn't require breaking the 200 SMA; A short position should be tactical, not a directional bet against the long-term trend
→ vs conservative: The conservative's 6 of 7 bearish technical factors are lagging indicators showing a short-term sentiment flush, not a fundamental break—until the 200 SMA at $319.38 gives way on a weekly close, this is a buying opportunity
→ vs conservative: The $309 stop loss is appropriately sized at 8.4% below entry, not too tight, with 1.5-2% position sizing being measured rather than aggressive
→ vs conservative: Q2 2026 special charges of $4.39 billion are one-time noise around a record signal of revenue, NII expansion, and accelerating ROE
→ vs neutral: Waiting for confirmation (close above $346, MACD crossover, RSI divergence) means buying at $352+ and giving up 4% of entry—the edge is buying the fear, not the confirmation
→ vs conservative: Higher-for-longer Fed is a gift for JPM: sticky deposits, repricing loan book, elevated NIM with $25.5B NII confirming 10% growth trajectory
| ATR(14) |
| 6.80 |
| neutral |
| VWMA (30-day) | 348.98 | bearish |
Support: 338.73 · 335.28 · 329.99 · 319.38 | Resistance: 346.01 · 351.82 · 353.35 · 364.91
The technical analysis reveals JPMorgan Chase in a defensive short-term setup with 6 of 7 factors leaning bearish. Price has declined from an August 12 high of $366.09 to close at $338.56 on September 24, sitting essentially at the lower Bollinger Band ($338.73). Short-term momentum is bearish with a clear bearish stack (price < 10 EMA < 50 SMA), while the 200 SMA at $319.38 still anchors a constructive longer-term bias. The immediate trading range is defined by resistance at $346.01 (10 EMA) and support at $338.73 (lower Bollinger band), with a critical structural support at $319.38. Volume analysis shows distribution-style signatures with notable selling spikes on September 18 (18.3M shares), September 22 (11.5M shares), and September 15 (14.0M shares), suggesting the path of least resistance remains lower until a high-volume reversal materializes.
Market Cap
$899.96 B
TTM P/E
14.52x
Forward P/E
13.55x
PEG Ratio
1.57
Price / Book
2.55x
EPS (TTM)
$23.32
Forward EPS
$24.99
Dividend Yield
1.96%
Beta
0.975
52-Week High
$366.50
52-Week Low
$279.10
Book Value / Share
$133.01
ROE
17.79%
ROA
1.36%
Net Margin
34.92%
Operating Margin
50.39%
Revenue (TTM)
$186.33B
Total Assets (Q2 2026)
$5,015.1 B
Net Loans (Q2 2026)
$1,516.3 B
Total Debt (Q2 2026)
$533.0 B
Common Stock Equity (Q2 2026)
$353.6 B
Tangible Book Value (Q2 2026)
$289.3 B
Retained Earnings (Q2 2026)
$445.0 B
Q2 2026 Revenue
$52,852 M
Q2 2026 Net Interest Income
$25,511 M
Q2 2026 Pre-Tax Income
$27,516 M
Q2 2026 Net Income
$21,155 M
Q2 2026 Diluted EPS
$7.70
Q2 2026 Diluted Shares
2,694 M
Q2 2026 Special Charges
$4.39 B
Q2 2026 Buybacks
$8.79 B
Q2 2026 Dividends Paid
$4.34 B
Annualized Capital Return
~$50-52B
Strengths
Concerns
JPMorgan Chase delivered blowout Q2 2026 results with record quarterly revenue of $52.9B (+17.8% YoY) and EPS of $7.70 (+47% YoY), driven by NIM expansion and strong operating leverage. The bank maintains best-in-class profitability metrics (17.79% ROE, 34.92% net margin) and continues its aggressive ~$50-52B annualized capital return program, returning 74-80% of net income to shareholders through dividends and buybacks. While valuation is premium (P/B 2.55x) and Q2 had $4.39B in special charges requiring monitoring, the fortress balance sheet, tangible book value compounding (+6.2% YoY), and earnings momentum support a high-quality fundamental profile.
Macro: The dominant theme is a sharp Treasury yield spike with 10Y at 2007 highs (~5%) and 30Y at 2004 highs. Markets are pricing 97% probability of zero Fed cuts in 2026, with recession odds at 10% (+1pp week-over-week). The macro regime is 'higher for even longer' — hawkish hold/hike, not a Fed put. For JPM: NIM tailwind (steeper curve, strong deposit franchise), trading revenue tailwind (FICC volatility), but headwinds from CRE cap-rate pressure, mortgage origination collapse, and eventual credit cycle deterioration.